Hemagen Diagnostics (Hemagen Diagnostics) Other Long Term Assets : $0.07 Mil (As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Other Long Term Assets?

Hemagen Diagnostics's other long-term assets for the quarter that ended in Sep. 2012 was $0.07 Mil.

Hemagen Diagnostics's quarterly other long-term assets declined from Mar. 2012 ($0.08 Mil) to Jun. 2012 ($0.06 Mil) but then increased from Jun. 2012 ($0.06 Mil) to Sep. 2012 ($0.07 Mil).

Hemagen Diagnostics's annual other long-term assets declined from Sep. 2010 ($0.08 Mil) to Sep. 2011 ($0.05 Mil) but then increased from Sep. 2011 ($0.05 Mil) to Sep. 2012 ($0.07 Mil).

Hemagen Diagnostics Other Long Term Assets Historical Data

The historical data trend for Hemagen Diagnostics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Other Long Term Assets Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Other Long Term Assets

Get a 7-Day Free Trial

0.55

0.30

0.08

0.05

0.07

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
Other Long Term Assets	Get a 7-Day Free Trial															0.05	0.06	0.08	0.06	0.07

Hemagen Diagnostics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines